Nouscom Employee Directory
Biotechnology ResearchBasel-stadt, Switzerland51-200 Employees
Nouscom is a clinical-stage biotechnology company based in Basel, Switzerland, focused on cancer immunotherapy via a proprietary viral-vector platform. It develops both off-the-shelf and personalized neoantigen immunotherapies aimed at provoking durable T cell responses in cancer patients. The lead program, NOUS-209, targets cancer interception in Lynch Syndrome carriers and is moving toward a global registrational trial expected to launch in the first half of 2026, following positive regulatory feedback. A second program, NOUS-PEV, provides a personalized immunotherapy for advanced solid tumors and is supported by a fully automated GMP manufacturing process enabling scalable delivery within eight weeks. The platform has clinical validation in over 170 patients, and the company is backed by several life sciences investors; it employs between 51 and 200 people.
1-888-653-2347 
support@leadiq.com 
